The Discounted Cash Flow (DCF) valuation of Nuvo Pharmaceuticals Inc (MRV.TO) is (4.99) CAD. With the latest stock price at 1.35 CAD, the upside of Nuvo Pharmaceuticals Inc based on DCF is -469.6%.
Note: valuation result may not be accurate due to the low predictability of business.
| Range | Selected | |
| WACC / Discount Rate | 5.3% - 5.7% | 5.5% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (5.60) - 1.58 | (4.99) |
| Upside | -515.2% - 17.0% | -469.6% |